Displaying drugs 951 - 975 of 2797 in total
Name | Weight | Structure | Description | Categories |
---|---|---|---|---|
Besifloxacin | 393.84 C19H21ClFN3O3 | A fluoroquinolone antibiotic agent used for the treatment of bacterial conjunctivitis. | Fluoroquinolones | |
Iodoform | 393.732 CHI3 | No approved therapeutic indications. | Medicated Dressings With Antiinfectives | |
Lumateperone | 393.506 C24H28FN3O | A novel 2nd generation antipsychotic used to manage both positive and negative symptoms in patients with schizophrenia. | Butyrophenone Derivatives | |
Amsacrine | 393.459 C21H19N3O3S | A cytotoxic agent used to induce remission in acute adult leukemia that is not adequately responsive to other agents. | Aminoacridines / Intercalating Agents | |
Daprodustat | 393.44 C19H27N3O6 | A small-molecule hypoxia-inducible factor prolyl hydroxylase inhibitor used for the treatment of anemia in patients with chronic kidney disease. | Amino Acids / Amino Acids, Peptides, and Proteins / Antianemic Preparations / BCRP/ABCG2 Substrates / Blood and Blood Forming Organs / Cytochrome P-450 CYP2C8 Inhibitors / Cytochrome P-450 CYP2C8 Inhibitors (strength unknown) / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor / Hypoxia-Inducible Factor-Proline Dioxygenases, antagonists & inhibitors / OAT1/SLC22A6 Substrates / OAT3/SLC22A8 Substrates / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / Pyrimidines / Pyrimidinones | |
Erlotinib | 393.4357 C22H23N3O4 | An EGFR tyrosine kinase inhibitor used to treat certain small cell lung cancers or advanced metastatic pancreatic cancers. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Protein Kinase Inhibitors | |
Fruquintinib | 393.399 C21H19N3O5 | A VEGF receptor inhibitor used to treat metastatic colorectal cancer. | Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors | |
Pentetic acid | 393.349 C14H23N3O10 | DTPA is widely used in industry and medicine. As a medical agent, it is approved for its use in medical imaging and for the decorporation of internally deposited radionuclides. It... | Acetates / Antidotes / Chelating Agents / Iron Chelating Agents / Lead Chelator / Polyamines | |
Deoxycholic acid | 392.572 C24H40O4 | A cytolytic agent injected subcutaneously to improve the appearance submental fat. | Cholagogues and Choleretics / Cholic Acids / Cytolytic Agent | |
Ursodeoxycholic acid | 392.572 C24H40O4 | A bile acid used for the treatment of primary biliary cirrhosis (PBC). | Bile Acid Preparations / Bile acids and derivatives | |
Chenodeoxycholic acid | 392.572 C24H40O4 | A bile acid used for the treatment of primary biliary cirrhosis. | Bile Acid Preparations / Bile acids and derivatives | |
Trospium | 392.518 C25H30NO3 | An antimuscarinic agent used to treat the symptoms of overactive bladder (OAB). | Drugs for Urinary Frequency and Incontinence | |
Tiotropium | 392.512 C19H22NO4S2 | A long-acting bronchodilator used in the management of chronic obstructive pulmonary disease (COPD). | Agents producing tachycardia | |
Ivacaftor | 392.4907 C24H28N2O3 | A cystic fibrosis transmembrane conductance regulator (CFTR) potentiator used alone or in combination products to treat cystic fibrosis in patients who have specific genetic mutations that are responsive to the medication. | Chloride Channel Agonists / Cystic Fibrosis Transmembrane Conductance Regulator Potentiators | |
Indacaterol | 392.4907 C24H28N2O3 | An inhaled long-acting beta-2 adrenergic agonist used to relax bronchial smooth muscle and improve symptoms and airflow obstruction caused by Chronic Obstructive Pulmonary Disease (COPD) and moderate to severe asthma. | Agents producing tachycardia / Agents that produce hypertension | |
Betamethasone | 392.4611 C22H29FO5 | A systemic corticosteroid used to relieve inflammation in various conditions, including but not limited to allergic states, dermatologic disorders, gastrointestinal diseases, and hematological disorders. | Corticosteroids Acting Locally / Corticosteroids, Potent (Group III) / Glucocorticoids | |
Dexamethasone | 392.4611 C22H29FO5 | A glucocorticoid available in various modes of administration that is used for the treatment of various inflammatory conditions, including bronchial asthma, as well as endocrine and rheumatic disorders. | Corticosteroids for Local Oral Treatment / Corticosteroids, Moderately Potent (Group II) | |
Sparfloxacin | 392.3998 C19H22F2N4O3 | A fluoroquinolone antibiotic used to treat bacterial respiratory infections and sinusitis. | Anti-Bacterial Agents / Fluoroquinolones | |
Aurothioglucose | 392.18 C6H11AuO5S | A gold compound used in the treatment of rheumatoid arthritis. | Gold Preparations | |
Dimetotiazine | 391.55 C19H25N3O2S2 | Dimetotiazine has considerable antiemetic & serotonin antagonistic action used mainly in allergic skin conditions. | Histamine H1 Antagonists | |
Ethylhexyl methoxycrylene | 391.511 C25H29NO3 | Ethylhexyl methoxycrylene is employed as a photostabilizing agent in various sunscreen products . | Not Available | |
Benzgalantamine | 391.467 C24H25NO4 | Not Annotated | Alkaloids / Amaryllidaceae Alkaloids / Benzazepines / Heterocyclic Compounds, Fused-Ring | |
Flavoxate | 391.4596 C24H25NO4 | A muscarinic antagonist and spasmolytic used for the symptomatic relief of conditions associated with lack of muscle control in the bladder, such as dysuria, urgency, and nocturia. | Drugs for Urinary Frequency and Incontinence | |
Permethrin | 391.288 C21H20Cl2O3 | An insecticide used to prevent infestation with Sarcoptes scabiei (scabies). | Pyrethrines, Incl. Synthetic Compounds | |
Meclizine | 390.948 C25H27ClN2 | A histamine H1 antagonist used to treat nausea, vomiting, and dizziness associated with motion sickness. | Piperazine Derivatives |
Displaying drugs 951 - 975 of 2797 in total